Orlistat Market Insights, Demand, Analysis, Share, Forecast: 2024-2033

"The Business Research Company recently released a comprehensive report on the Global Orlistat Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18422&type=smp

According to The Business Research Company's, The orlistat market size has grown strongly in recent years. It will grow from $2.85 billion in 2023 to $3.03 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growing awareness of obesity-related health risks, regulatory approvals for orlistat as a prescription medication, the availability of orlistat in lower doses over-the-counter, physician recommendations, and increasing costs of obesity-related healthcare.

The orlistat market size is expected to see strong growth in the next few years. It will grow to $3.91 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing healthcare spending on obesity treatments, sedentary lifestyles along with unhealthy eating habits, government programs promoting weight loss and healthy living, the aging population, and prescriptions to over-the-counter shift. Major trends in the forecast period include AI-driven diet plans, telehealth services, automated devices that remind patients to take their medication and track adherence, virtual reality workouts, and digital therapeutics.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/orlistat-global-market-report

Market Drivers and Trends:

Increasing obesity rates are expected to propel the growth of the orlistat market going forward. Obesity is a medical condition characterized by excessive body fat accumulation, which can negatively impact health. It is commonly measured by a body mass index (BMI) of 30 or higher. Obesity is increasing due to factors such as poor diet, lack of physical activity, and sedentary lifestyles. Orlistat is used in obesity management by inhibiting the absorption of dietary fats, which helps reduce body weight and maintain weight loss. It is often prescribed alongside a reduced-calorie diet and exercise for more effective results. For instance, in March 2022, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, over 1 billion individuals globally were affected by obesity, comprising 650 million adults, 340 million adolescents, and 39 million children. This figure continues to rise, and it is projected that by 2025, around 167 million people, including both adults and children, will experience deteriorating health due to being overweight or obese. Therefore, increasing obesity rates are driving the growth of the orlistat market.

Major companies operating in the orlistat market are developing innovative products, such as weight loss drugs, to enhance personal hygiene and comfort through advanced technology and design. A weight loss drug refers to a medication designed to help individuals reduce body weight by suppressing appetite, increasing metabolism, or blocking fat absorption. For instance, in November 2023, Eli Lilly and Company, a US-based pharmaceutical company, received US Food and Drug Administration (FDA) approval for Zepbound (tirzepatide) injection, a new weight loss drug. It is the first and only approved treatment that activates two incretin hormone receptors, GIP and GLP-1, addressing an underlying cause of excess weight. Zepbound is indicated for use as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI =30 kg/m²) or overweight (BMI =27 kg/m²) with at least one weight-related condition.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Roche Holding AG, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd.

Orlistat Market 2024 Key Insights:

• The orlistat market size is expected to see strong growth in the next few years. It will grow to $3.91 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.
• Rising Obesity Rates And Their Impact On The Growth Of The Orlistat Market
• Advancements In Weight Loss Drug Boost Orlistat Market 
• North America was the largest region in the orlistat market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=18422&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"""Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.